iCo Therapeutics Company Profile (OTCMKTS:ICOTF)

About iCo Therapeutics (OTCMKTS:ICOTF)

iCo Therapeutics logoiCo Therapeutics Inc. (iCo) is a Canada-based biotechnology company principally focused on the identification, development and commercialization of drug candidates to treat sight-and life-threatening diseases. The Company principally focuses on in-licensing drug candidates with a clinical history, and re-dose, reformulate and develop drug candidates for the treatment of sight-and life-threatening diseases. The Company's product candidates include iCo-007, iCo-008 and an Oral AmpB Delivery System. The Company has initiated Phase II clinical trial for iCo-007. iCo-008 is a human monoclonal antibody that is offered to treat sight threatening forms of allergic conjunctivitis by neutralizing eotaxin-1, a ligand to the chemokine receptor CCR3. Oral AmpB Delivery System is a toxic option for the treatment of serious systemic fungal infections. The Company has completed pre-clinical studies for iCo's Oral AmpB Delivery System.

Industry, Sector and Symbol: Capitalization:
  • Market Cap: $2.61 million
  • Outstanding Shares: 84,457,000
Average Prices:
  • 50 Day Moving Avg: $0.03
  • 200 Day Moving Avg: $0.03
  • 52 Week Range: $0.02 - $0.07
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.0000
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: $0.02 per share
  • Price / Book: 1.55
  • EBIDTA: ($883,699.00)
  • Return on Equity: -59.51%
  • Return on Assets: -57.48%
  • Current Ratio: 18.36%
  • Quick Ratio: 18.36%
  • Average Volume: 2,659 shs.
  • Beta: 2.57

Frequently Asked Questions for iCo Therapeutics (OTCMKTS:ICOTF)

What is iCo Therapeutics' stock symbol?

iCo Therapeutics trades on the OTCMKTS under the ticker symbol "ICOTF."

How were iCo Therapeutics' earnings last quarter?

iCo Therapeutics Inc (OTCMKTS:ICOTF) posted its quarterly earnings data on Wednesday, November, 27th. The company reported ($0.01) EPS for the quarter. View iCo Therapeutics' Earnings History.

Who are some of iCo Therapeutics' key competitors?

How do I buy iCo Therapeutics stock?

Shares of iCo Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of iCo Therapeutics stock cost?

One share of iCo Therapeutics stock can currently be purchased for approximately $0.03.

Analyst Ratings

Consensus Ratings for iCo Therapeutics (OTCMKTS:ICOTF) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for iCo Therapeutics (OTCMKTS:ICOTF)
No equities research coverage for this company has been tracked by MarketBeat.com


Earnings History for iCo Therapeutics (OTCMKTS:ICOTF)
Earnings by Quarter for iCo Therapeutics (OTCMKTS:ICOTF)
Earnings History by Quarter for iCo Therapeutics (OTCMKTS:ICOTF)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/29/2014Q1 2014($0.02)($0.01)ViewN/AView Earnings Details
4/24/2014Q4 2013($0.02)($0.02)ViewN/AView Earnings Details
11/27/2013Q3($0.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for iCo Therapeutics (OTCMKTS:ICOTF)

No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for iCo Therapeutics (OTCMKTS:ICOTF)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for iCo Therapeutics (OTCMKTS:ICOTF)
No insider trades for this company have been tracked by MarketBeat.com


Headline Trends for iCo Therapeutics (OTCMKTS:ICOTF)
Latest Headlines for iCo Therapeutics (OTCMKTS:ICOTF)



iCo Therapeutics (ICOTF) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by MarketBeat.com Staff